Bought TXG @ 11.04 $ a share for 10x

I decided to buy 10X Genomics Inc. (TXG) for two reasons. Firstly, I need to diversify my portfolio, and the medical field is a great place to start. The reason I chose TXG specifically is their recently unveiled plan and the potential of their technology to revolutionize their field. As Ben Hindson, Co-Founder and Chief Scientific Officer of 10X Genomics, stated, “After a record year of innovation, we continue to push the boundaries of what’s possible in single cell and spatial biology, taking on the hardest challenges so researchers can make the biggest impact. Our 2025 roadmap will once again raise the bar for the field and enable researchers to tackle bigger questions, analyze more samples, and extract deeper insights from their data.” This commitment to innovation and advancing genetic engineering makes TXG an extremely valuable investment for the future.